List of Tables
Table 1. Global Dementia Diagnosis Solutions Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dementia Diagnosis Solutions Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dementia Diagnosis Solutions Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dementia Diagnosis Solutions Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dementia Diagnosis Solutions Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Dementia Diagnosis Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Dementia Diagnosis Solutions Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Dementia Diagnosis Solutions by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Diagnosis Solutions as of 2024)
Table 11. Global Dementia Diagnosis Solutions Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Dementia Diagnosis Solutions Companies Headquarters
Table 13. Global Dementia Diagnosis Solutions Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Dementia Diagnosis Solutions Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Dementia Diagnosis Solutions Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Dementia Diagnosis Solutions Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Dementia Diagnosis Solutions Revenue by Application (2026-2031) & (US$ Million)
Table 21. Dementia Diagnosis Solutions High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Dementia Diagnosis Solutions Growth Accelerators and Market Barriers
Table 25. North America Dementia Diagnosis Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Dementia Diagnosis Solutions Growth Accelerators and Market Barriers
Table 27. Europe Dementia Diagnosis Solutions Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Dementia Diagnosis Solutions Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Dementia Diagnosis Solutions Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Dementia Diagnosis Solutions Investment Opportunities and Key Challenges
Table 31. Central and South America Dementia Diagnosis Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Dementia Diagnosis Solutions Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Dementia Diagnosis Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Johnson & Johnson Corporation Information
Table 35. Johnson & Johnson Description and Major Businesses
Table 36. Johnson & Johnson Product Features and Attributes
Table 37. Johnson & Johnson Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Johnson & Johnson Revenue Proportion by Product in 2024
Table 39. Johnson & Johnson Revenue Proportion by Application in 2024
Table 40. Johnson & Johnson Revenue Proportion by Geographic Area in 2024
Table 41. Johnson & Johnson Dementia Diagnosis Solutions SWOT Analysis
Table 42. Johnson & Johnson Recent Developments
Table 43. Corium Corporation Information
Table 44. Corium Description and Major Businesses
Table 45. Corium Product Features and Attributes
Table 46. Corium Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Corium Revenue Proportion by Product in 2024
Table 48. Corium Revenue Proportion by Application in 2024
Table 49. Corium Revenue Proportion by Geographic Area in 2024
Table 50. Corium Dementia Diagnosis Solutions SWOT Analysis
Table 51. Corium Recent Developments
Table 52. Roche Corporation Information
Table 53. Roche Description and Major Businesses
Table 54. Roche Product Features and Attributes
Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Revenue Proportion by Product in 2024
Table 57. Roche Revenue Proportion by Application in 2024
Table 58. Roche Revenue Proportion by Geographic Area in 2024
Table 59. Roche Dementia Diagnosis Solutions SWOT Analysis
Table 60. Roche Recent Developments
Table 61. Quanterix Corporation Information
Table 62. Quanterix Description and Major Businesses
Table 63. Quanterix Product Features and Attributes
Table 64. Quanterix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Quanterix Revenue Proportion by Product in 2024
Table 66. Quanterix Revenue Proportion by Application in 2024
Table 67. Quanterix Revenue Proportion by Geographic Area in 2024
Table 68. Quanterix Dementia Diagnosis Solutions SWOT Analysis
Table 69. Quanterix Recent Developments
Table 70. Eli Lilly & Company Corporation Information
Table 71. Eli Lilly & Company Description and Major Businesses
Table 72. Eli Lilly & Company Product Features and Attributes
Table 73. Eli Lilly & Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Eli Lilly & Company Revenue Proportion by Product in 2024
Table 75. Eli Lilly & Company Revenue Proportion by Application in 2024
Table 76. Eli Lilly & Company Revenue Proportion by Geographic Area in 2024
Table 77. Eli Lilly & Company Dementia Diagnosis Solutions SWOT Analysis
Table 78. Eli Lilly & Company Recent Developments
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Product Features and Attributes
Table 82. Novartis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Novartis Recent Developments
Table 84. Allergan Corporation Information
Table 85. Allergan Description and Major Businesses
Table 86. Allergan Product Features and Attributes
Table 87. Allergan Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Allergan Recent Developments
Table 89. C₂N Diagnostics Corporation Information
Table 90. C₂N Diagnostics Description and Major Businesses
Table 91. C₂N Diagnostics Product Features and Attributes
Table 92. C₂N Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. C₂N Diagnostics Recent Developments
Table 94. Combinostics Corporation Information
Table 95. Combinostics Description and Major Businesses
Table 96. Combinostics Product Features and Attributes
Table 97. Combinostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Combinostics Recent Developments
Table 99. Cognoptix Corporation Information
Table 100. Cognoptix Description and Major Businesses
Table 101. Cognoptix Product Features and Attributes
Table 102. Cognoptix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Cognoptix Recent Developments
Table 104. GT Diagnostics Corporation Information
Table 105. GT Diagnostics Description and Major Businesses
Table 106. GT Diagnostics Product Features and Attributes
Table 107. GT Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. GT Diagnostics Recent Developments
Table 109. Quest Diagnostics Corporation Information
Table 110. Quest Diagnostics Description and Major Businesses
Table 111. Quest Diagnostics Product Features and Attributes
Table 112. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Quest Diagnostics Recent Developments
Table 114. DiADeM (Diagnosing Advanced Dementia Mandate) Corporation Information
Table 115. DiADeM (Diagnosing Advanced Dementia Mandate) Description and Major Businesses
Table 116. DiADeM (Diagnosing Advanced Dementia Mandate) Product Features and Attributes
Table 117. DiADeM (Diagnosing Advanced Dementia Mandate) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. DiADeM (Diagnosing Advanced Dementia Mandate) Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Dementia Diagnosis Solutions Product Picture
Figure 2. Global Dementia Diagnosis Solutions Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Traditional Diagnostic Technology Product Picture
Figure 4. Bioinformatics Diagnostic Technology Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dementia Diagnosis Solutions Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Medical
Figure 8. Community
Figure 9. Family
Figure 10. Dementia Diagnosis Solutions Report Years Considered
Figure 11. Global Dementia Diagnosis Solutions Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 13. Global Dementia Diagnosis Solutions Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Dementia Diagnosis Solutions Revenue Market Share by Region (2020-2031)
Figure 15. Global Dementia Diagnosis Solutions Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Traditional Diagnostic Technology Revenue Market Share by Player in 2024
Figure 18. Bioinformatics Diagnostic Technology Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Dementia Diagnosis Solutions Revenue Market Share by Type (2020-2031)
Figure 21. Global Dementia Diagnosis Solutions Revenue Market Share by Application (2020-2031)
Figure 22. North America Dementia Diagnosis Solutions Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Dementia Diagnosis Solutions Revenue (US$ Million) in 2024
Figure 24. North America Dementia Diagnosis Solutions Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Dementia Diagnosis Solutions Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Dementia Diagnosis Solutions Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Dementia Diagnosis Solutions Revenue (US$ Million) in 2024
Figure 31. Europe Dementia Diagnosis Solutions Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Dementia Diagnosis Solutions Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 34. France Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Dementia Diagnosis Solutions Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Dementia Diagnosis Solutions Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Dementia Diagnosis Solutions Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Dementia Diagnosis Solutions Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 46. India Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Dementia Diagnosis Solutions Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Dementia Diagnosis Solutions Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Dementia Diagnosis Solutions Revenue (US$ Million) in 2024
Figure 54. Central and South America Dementia Diagnosis Solutions Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Dementia Diagnosis Solutions Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Dementia Diagnosis Solutions Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Dementia Diagnosis Solutions Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Dementia Diagnosis Solutions Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Dementia Diagnosis Solutions Revenue (US$ Million) in 2024
Figure 60. South America Dementia Diagnosis Solutions Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Dementia Diagnosis Solutions Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Dementia Diagnosis Solutions Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Dementia Diagnosis Solutions Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Dementia Diagnosis Solutions Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Dementia Diagnosis Solutions Revenue (2020-2025) & (US$ Million)
Figure 66. Dementia Diagnosis Solutions Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
